GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CG Oncology Inc (NAS:CGON) » Definitions » Sale Of Investment

CG Oncology (CG Oncology) Sale Of Investment : $145.87 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is CG Oncology Sale Of Investment?

CG Oncology's sale of investment for the three months ended in Mar. 2024 was $145.87 Mil. It means CG Oncology gained $145.87 Mil from selling investments. CG Oncology's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was $145.87 Mil.

Compared with last quarter ($0.00 Mil in Dec. 2023 ), CG Oncology gained more money from selling investments in Mar. 2024 ($145.87 Mil).


CG Oncology Sale Of Investment Historical Data

The historical data trend for CG Oncology's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CG Oncology Sale Of Investment Chart

CG Oncology Annual Data
Trend Dec21 Dec22 Dec23
Sale Of Investment
- - 396.42

CG Oncology Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial - - - - 145.87

CG Oncology Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $145.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CG Oncology Sale Of Investment Related Terms

Thank you for viewing the detailed overview of CG Oncology's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


CG Oncology (CG Oncology) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette Guerin (BCG) therapy, the current standard-of-care for high-risk NMIBC.

CG Oncology (CG Oncology) Headlines